GREY:ICOTF - Post by User
Comment by
jlunminon Apr 17, 2015 1:08pm
124 Views
Post# 23641022
RE:From Zack's...
RE:From Zack's...calenderj wrote: We continue to believe that Immune has enormous upside potential based on the development of bertilimumab and the potential to partner AmiKet over the near-term. We are maintaining our 'Buy' rating and our price target of $6 per share
$6 per share = $4 million for the 655K shares and $400K for the 123K warrants at a strike price of $2.63. So $6.4 million JUST for the value of IMNP stock and that's where the market cap of ICO is right now at 7.5 cents.
Of course IMNP has a while to go to get to $6 but that just goes to show you how much upside ICO has. Presumably IMNP will only get to $6 upon success and if they are successful iCO-008 is worth a lot more because ICO licensed it out to IMNP for certain diseases but is keeping it for many others and success in one, like FDA approval, really helps the chances for future successes elsewhere.